Rosenblum Mark J - Insider Non-Derivative Transactions at Salarius Pharmaceuticals, Inc. (SLRX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 20, 2025, Rosenblum Mark J's relationship to Salarius Pharmaceuticals, Inc. (SLRX) is Officer (Exec VP Finance, CFO), and currently has 20,177 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SLRX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Rosenblum Mark J - Insider Non-Derivative Transactions of SLRX Common Stock

Rosenblum Mark J - Insider Non-Derivative Transactions at SLRX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 21, 2025	P -- (Common Stock)	20000	0.8	20177
Feb 14, 2023	Acquisition -- (Common Stock)	6432	0	21851
Jan 4, 2023	Acquisition -- (Common Stock)	8000	0	15419